Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
- 1 March 1993
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 59 (3) , 511-515
- https://doi.org/10.1016/s0015-0282(16)55791-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosisFertility and Sterility, 1992
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-upFertility and Sterility, 1992
- A comparison of nafarelin acetate and danazol in the treatment of endometriosisFertility and Sterility, 1990
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- Recurrent endometriosis: Incidence, management, and prognosisAmerican Journal of Obstetrics and Gynecology, 1983
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-upFertility and Sterility, 1982
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982